We are live on
!
Find out more
CCM
Camber Capital Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
8.19%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$972M
AUM Growth
–
Cap. Flow
+$939M
Cap. Flow
% of AUM
96.54%
Top 10 Holdings %
Top 10 Hldgs %
55.08%
Holding
43
New
43
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$59.9M |
| 2 |
Viatris
VTRS
|
+$53.8M |
| 3 |
Quest Diagnostics
DGX
|
+$47.7M |
| 4 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
+$42.1M |
| 5 |
HOLX
Hologic
HOLX
|
+$41.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 68.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $120M | 12.34% |
+750,000
| New | +$121M |
|
|
2
Elevance Health
ELV
$81.5B
| $65.5M | 6.73% |
+800,000
| New | +$59.9M |
|
|
3
Viatris
VTRS
$20.8B
| $55.9M | 5.74% |
+1,800,000
| New | +$53.8M |
|
|
4
CALL
Elevance Health
ELV
$81.5B
| $53.2M | 5.47% |
+650,000
| New | +$48.6M |
|
|
5
Quest Diagnostics
DGX
$26B
| $48.5M | 4.99% |
+800,000
| New | +$47.7M |
|
|
VHS
6
DELISTED
VANGUARD HEALTH SYS INC COM STK (DE)
VHS
| $41.5M | 4.27% |
+2,000,000
| New | +$28.3M |
|
|
VOLC
7
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $39.9M | 4.1% |
+2,200,000
| New | +$42.1M |
|
|
HOLX
8
DELISTED
Hologic
HOLX
| $38.6M | 3.97% |
+2,000,000
| New | +$41.8M |
|
|
MASI
9
DELISTED
Masimo
MASI
| $37.1M | 3.82% |
+1,750,000
| New | +$36.8M |
|
10
Cardinal Health
CAH
$53.7B
| $35.4M | 3.64% |
+750,000
| New | +$34.3M |
|
11
Humana
HUM
$43.9B
| $33.8M | 3.47% |
+400,000
| New | +$31.6M |
|
12
CONMED
CNMD
$1.3B
| $31.2M | 3.21% |
+1,000,000
| New | +$32.4M |
|
13
Alnylam Pharmaceuticals
ALNY
$38.3B
| $31M | 3.19% |
+1,000,000
| New | +$26.6M |
|
14
Teva Pharmaceuticals
TEVA
$40.4B
| $29.4M | 3.02% |
+750,000
| New | +$29.2M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $25.2M | 2.6% |
+200,000
| New | +$22.6M |
|
|
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
| $22.3M | 2.29% |
+850,000
| New | +$20.7M |
|
|
MAKO
17
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $21.7M | 2.23% |
+1,800,000
| New | +$20.5M |
|
|
GIVN
18
DELISTED
GIVEN IMAGING LTD
GIVN
| $21M | 2.16% |
+1,500,000
| New | +$22.8M |
|
19
Universal Health Services
UHS
$10.2B
| $16.7M | 1.72% |
+250,000
| New | +$16.5M |
|
20
AngioDynamics
ANGO
$605M
| $15M | 1.54% |
+1,327,500
| New | +$14.1M |
|
21
UnitedHealth
UNH
$382B
| $13.1M | 1.35% |
+200,000
| New | +$12.4M |
|
|
ITMN
22
DELISTED
INTERMUNE INC
ITMN
| $13M | 1.34% |
+1,350,000
| New | +$12.9M |
|
|
DSCI
23
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $12.7M | 1.3% |
+950,000
| New | +$12.2M |
|
|
ALR
24
DELISTED
Alere Inc
ALR
| $12.3M | 1.26% |
+500,000
| New | +$12.9M |
|
|
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $12M | 1.24% |
+800,000
| New | +$10.6M |
|
Similar funds
PP
SAF
NRD
FC
GIM
SC
BWA
CCP
Camber Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Camber Capital Management, which disclosed 43 positions worth $972M. Its ten largest holdings account for 55% of the portfolio.
Its largest position is Elevance Health: 800,000 shares worth $65.5M.
By sector, the portfolio is most concentrated in Healthcare at 68% of assets.
- Camber Capital Management's largest Q2 2013 buy was Elevance Health: 800,000 shares worth $65.5M.
- Camber Capital Management's ten largest holdings make up 55% of its $972M portfolio in Q2 2013.
- Camber Capital Management disclosed 43 positions in Q2 2013, its first 13F filing on record.
Based on Camber Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.